Search hospitals > Ohio > Columbus

Arthur G. James Cancer Hospital - Ohio State University

Claim this profile
Columbus, Ohio 43202
Global Leader in Lymphoma
Global Leader in Lung Cancer
Conducts research for Breast Cancer
Conducts research for Leukemia
Conducts research for Acute Myelogenous Leukemia
491 reported clinical trials
16 medical researchers
Photo of Arthur G. James Cancer Hospital - Ohio State University in ColumbusPhoto of Arthur G. James Cancer Hospital - Ohio State University in ColumbusPhoto of Arthur G. James Cancer Hospital - Ohio State University in Columbus

Summary

Arthur G. James Cancer Hospital - Ohio State University is a medical facility located in Columbus, Ohio. This center is recognized for care of Lymphoma, Lung Cancer, Breast Cancer, Leukemia, Acute Myelogenous Leukemia and other specialties. Arthur G. James Cancer Hospital - Ohio State University is involved with conducting 491 clinical trials across 357 conditions. There are 16 research doctors associated with this hospital, such as Uma Borate, MD, Alice Mims, Sagar Sardesai, MD, and David O'Malley, MD.

Area of expertise

1Lymphoma
Global Leader
Arthur G. James Cancer Hospital - Ohio State University has run 61 trials for Lymphoma. Some of their research focus areas include:
Stage IV
Stage III
CCND1 positive
2Lung Cancer
Global Leader
Arthur G. James Cancer Hospital - Ohio State University has run 52 trials for Lung Cancer. Some of their research focus areas include:
Stage IV
Stage III
BRAF positive

Top PIs

Clinical Trials running at Arthur G. James Cancer Hospital - Ohio State University

Myelofibrosis
Acute Myeloid Leukemia
Chronic Lymphocytic Leukemia
Lung Cancer
Multiple Myeloma
Acute Myelogenous Leukemia
Follicular Lymphoma
Mantle Cell Lymphoma
Breast Cancer
Myelodysplastic Syndrome
Image of trial facility.

Bomedemstat

for Blood Disorders

The primary purpose of the study is to transition participants into an extension study to collect long-term safety and efficacy data. The study will include participants who are safely tolerating bomedemstat, receiving clinical benefit from its use in estimation of the investigator, and have shown the following criteria: * Participants from the IMG-7289-202/MK-3543-005 (NCT05223920) study must have received at least 6 months of treatment with bomedemstat; * Essential thrombocythemia (ET) and polycythemia vera (PV) participants from studies other than IMG-7289-202/MK-3543-005 must have achieved confirmed hematologic remission. No hypothesis testing will be conducted in this study.
Recruiting2 awards Phase 32 criteria
Image of trial facility.

Pacritinib

for Myelofibrosis

This study (study ID PAC203 North America; PAC303 ex-North America) is evaluating 200 mg BID of pacritinib compared to physician's choice (P/C) therapy in patients with MF and severe thrombocytopenia (platelet count \<50,000/μL). Approximately 399 patients in total will be enrolled, randomized 2:1 to either pacritinib (approximately 266 patients) or to P/C therapy (approximately 133 patients) Condition or disease: Primary Myelofibrosis/Post-Polycythemia Vera Myelofibrosis/ Post-essential Thrombocythemia Myelofibrosis Intervention/treatment: Drug-Pacritinib
Recruiting2 awards Phase 319 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Arthur G. James Cancer Hospital - Ohio State University?
Where is Arthur G. James Cancer Hospital - Ohio State University located?
Who should I call to ask about financial aid or insurance network?
What insurance does Arthur G. James Cancer Hospital - Ohio State University accept?
What awards or recognition has Arthur G. James Cancer Hospital - Ohio State University received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security